Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection

Abstract

Of the patients with COVID-19 who received hydroxychloroquine with lopinavir or darunavir, 17% had ECG abnormalities, mainly related to age or in those with a history of cardiovascular disease.